“SAFETY, EFFICACY, AND EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN THE TREATMENT OF RELAPSED OR REFRACTORY CD30+ HODGKIN LYMPHOMA AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION: A SYSTEMATIC REVIEW” (2026) REMUNOM, 2(02), pp. 1–23. doi:10.66104/hkgjcw62.